In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: REX trades below a high-confidence fair value estimate of $48.88, implying an 18.6% upside, supported by multiple valuation methods. Strong financial health contrasts with low growth (1/5), elevating volatility and downside risk (75% below current price) per Monte Carlo analysis. Valuation uncertainty remains significant despite liquidity and leverage strengths.